ALDEYRA THERAPEUTICS INC (ALDX) Stock Analyst Ratings
USA - NASDAQ:ALDX - US01438T1060 - Common Stock
5.05 USD
+0.03 (+0.6%)
5.15 USD
+0.1 (+1.98%)
ChartMill assigns a Buy % Consensus number of 87% to ALDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.86. This target is 95.25% above the current price.
ALDX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ALDX.
In the previous month the buy percentage consensus was at a similar level.
ALDX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-07 | BTIG | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-06 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-17 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-10-17 | Citigroup | Maintains | Buy -> Buy |
| 2023-08-09 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-06-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-01 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-06-09 | Citigroup | Maintains | Buy |
| 2021-12-21 | SVB Leerink | Maintains | Outperform |
| 2021-12-21 | Citigroup | Maintains | Buy |
| 2021-03-12 | SVB Leerink | Initiate | Outperform |
| 2021-02-08 | HC Wainwright & Co. | Initiate | Buy |
ALDEYRA THERAPEUTICS INC / ALDX FAQ
What is the price target for ALDX stock?
12 analysts have analysed ALDX and the average price target is 9.86 USD. This implies a price increase of 95.25% is expected in the next year compared to the current price of 5.05.
Can you provide the consensus rating for ALDEYRA THERAPEUTICS INC stock?
The consensus rating for ALDEYRA THERAPEUTICS INC (ALDX) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.